Contact Us

U.S. Headquarters

Utah
421 Wakara Way
Suite 309
Salt Lake City, UT 84108

Operations

Send Invoices To:
1460 Broadway
New York, NY 10036

Indiana
9465 Counselors Row,
Suite 200, office 244,
Indianapolis, IN 46240

Renalytix AI PLC

Registered Office

Avon House
19 Stanwell Road
Penarth,
Cardiff, United Kingdom

Company Secretary: Salim Hamir

Enquiries

Renalytix AI

Media Enquiries
Sara Kienke
Tel: 801-447-2698
media@renalytixai.com

Walbrook PR Ltd

Media and Investor Relations
Tel: +44 (0)20 7933 8790
renalytix@walbrookpr.com

Latest News

03Aug

KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients

Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19 Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients.. Read More →
31Jul

Total Voting Rights

As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each,.. Read More →
27Jul

Over allotment option exercise raises an additional US$10.9m

Renalytix AI plc announces that the underwriters of its global offering of new ordinary shares.. Read More →